We are live on ! Find out more
Comerica Bank

Comerica Bank Portfolio holdings

AUM $25.1B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+24.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.8B
AUM Growth
+$458M
Cap. Flow
-$54.1M
Cap. Flow %
-0.39%
Top 10 Hldgs %
11.23%
Holding
2,299
New
107
Increased
1,221
Reduced
779
Closed
41

Top Buys

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$28.8M
2
AGN
Allergan plc
AGN
+$20.6M
3
GILD icon
Gilead Sciences
GILD
+$17.3M
4
PFE icon
Pfizer
PFE
+$16.9M
5
EMR icon
Emerson Electric
EMR
+$16.2M

Sector Composition

Rank Sector Weight
1 Financials 14.9%
2 Technology 13.51%
3 Industrials 10.88%
4 Healthcare 10.86%
5 Consumer Discretionary 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET icon
176
MetLife
MET
$62.4B
$14.6M 0.11%
270,260
-31,613
-10% -$1.54M
STZ icon
177
Constellation Brands
STZ
$22.5B
$14.4M 0.1%
67,757
+351
+0.5% +$69.5K
MRSH
178
Marsh
MRSH
$94.3B
$14.4M 0.1%
178,195
-9,472
-5% -$751K
TRV icon
179
Travelers Companies
TRV
$81.1B
$14.4M 0.1%
108,216
-4,759
-4% -$594K
PRU icon
180
Prudential Financial
PRU
$42.6B
$14.3M 0.1%
128,529
+1,480
+1% +$158K
LRCX icon
181
Lam Research
LRCX
$316B
$14.3M 0.1%
695,220
-58,450
-8% -$948K
SPG icon
182
Simon Property Group
SPG
$76.4B
$14.3M 0.1%
90,529
-128
-0.1% -$20.4K
DXC icon
183
DXC Technology
DXC
$1.91B
$14.2M 0.1%
+180,627
New +$12.8M
EFAV icon
184
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.35B
$14.2M 0.1%
198,478
-7,293
-4% -$514K
ZBH icon
185
Zimmer Biomet
ZBH
$18.8B
$14.1M 0.1%
119,357
+2,789
+2% +$322K
GXP
186
DELISTED
Great Plains Energy Incorporated
GXP
$14.1M 0.1%
427,692
+194
+0% +$5.94K
MON
187
DELISTED
Monsanto Co
MON
$14M 0.1%
115,874
+105
+0.1% +$12.4K
AVB icon
188
AvalonBay Communities
AVB
$27.5B
$14M 0.1%
77,172
-716
-0.9% -$134K
DAN icon
189
Dana Inc
DAN
$2.88B
$14M 0.1%
471,624
-81,379
-15% -$1.98M
SPY icon
190
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$14M 0.1%
54,378
+4,014
+8% +$990K
CFR icon
191
Cullen/Frost Bankers
CFR
$10.5B
$14M 0.1%
140,992
+1,200
+0.9% +$108K
CCI icon
192
Crown Castle
CCI
$34.6B
$13.9M 0.1%
131,016
-7,632
-6% -$780K
VCSH icon
193
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$13.9M 0.1%
173,432
+11,909
+7% +$954K
BP icon
194
BP
BP
$112B
$13.8M 0.1%
385,189
-13,334
-3% -$424K
PX
195
DELISTED
Praxair Inc
PX
$13.7M 0.1%
93,131
-3,258
-3% -$434K
DLR icon
196
Digital Realty Trust
DLR
$69.6B
$13.7M 0.1%
116,224
+49,643
+75% +$5.74M
ATVI
197
DELISTED
Activision Blizzard
ATVI
$13.5M 0.1%
206,933
+11,705
+6% +$730K
SPGI icon
198
S&P Global
SPGI
$124B
$13.5M 0.1%
86,445
+14,219
+20% +$2.16M
IEFA icon
199
iShares Core MSCI EAFE ETF
IEFA
$186B
$13.5M 0.1%
207,284
+5,797
+3% +$363K
TCBI icon
200
Texas Capital Bancshares
TCBI
$4.28B
$13.3M 0.1%
154,161
+172
+0.1% +$13.4K

Similar funds

Comerica Bank's Q3 2017 Portfolio in Review

As of Q3 2017, Comerica Bank held 2,299 positions worth $13.8B, up 3.4% from $13.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Comerica Bank's Q3 2017 filing shows 107 new, 1,221 increased, 779 reduced and 41 closed positions. Its largest new stake was Allergan plc: 88,644 shares worth $15.8M. The largest sale was AbbVie, an estimated $67.7M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Comerica Bank's largest Q3 2017 buy was Allergan plc: 88,644 shares worth $15.8M.
  • Comerica Bank added most to DuPont de Nemours in Q3 2017, an estimated $28.8M increase.
  • Comerica Bank's biggest Q3 2017 reduction was AbbVie, cutting an estimated $67.7M.
  • Comerica Bank fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $28.8M.
  • Comerica Bank's ten largest holdings make up 11% of its $13.8B portfolio in Q3 2017.
  • Comerica Bank opened 107 new positions and closed 41 in Q3 2017.
  • Comerica Bank's portfolio value rose 3.4% quarter-over-quarter to $13.8B.

Based on Comerica Bank's 13F filing for Q3 2017, filed 6 Nov 2017.